Last updated: August 2, 2025
Introduction
Denmark patent DK2213661 pertains to a specific pharmaceutical invention, featuring unique claims and scope that influence its market positioning and competitive landscape. Analyzing its scope, claims, and patent environment offers insight for stakeholders evaluating licensing, innovation potential, or legal considerations. This report synthesizes the patent’s technical coverage, the breadth of protections, and the broader patent landscape affecting DK2213661.
Patent Overview and Technical Field
DK2213661 is a Danish national patent granted for a pharmaceutical composition, method of treatment, or a novel formulation involving a specific active compound or combination. While details may vary, such patents typically claim innovations around a novel drug molecule, its use, or specific formulations that improve bioavailability, stability, or patient compliance.
Key features:
- Authentication of innovation typically resides in a new chemical entity, a novel use, or an improved formulation.
- The patent’s priority date and filing date anchor its novelty and inventive step considerations.
- The patent's scope influences its enforceability and market exclusivity.
Scope of the Patent Claims
Claims Analysis
The claims define the legal boundary of the patent's protection. They are categorized into independent and dependent claims:
-
Independent Claims:
- Usually encompass broad coverage, such as a novel compound or a method of treatment.
- For DK2213661, the primary independent claim likely covers a specific chemical entity or a pharmacological method involving the compound.
- Broader independent claims aim to prevent competitors from making minor modifications.
-
Dependent Claims:
- Narrower restrictions that specify particular embodiments, dosing regimens, formulations, or combinations.
- These claims refine protection around specific embodiments or usages.
Scope and Breadth
- The breadth of DK2213661’s claims directly impacts its strength against infringement and patent challenges.
- Broader claims may face scrutiny during examination for clarity and inventive step but provide wider market protection.
- Narrow claims, while easier to defend, limit protection to specific embodiments.
Key Claim Considerations
- Structure and Markush groups: Compound claims may specify chemical structures with variants; broader Markush claims can cover multiple derivatives.
- Use claims: Patents often claim new therapeutic uses, which expand coverage but require demonstration of novelty.
- Formulation claims: May include specific excipients or delivery systems, protecting proprietary formulations.
Claim Limitations and Vulnerabilities
- Claims overly broad or lacking clarity risk invalidation.
- If prior art discloses similar compounds or methods, the patent’s scope could be challenged.
- The patent’s claims must demonstrate non-obviousness and inventive step to withstand legal scrutiny.
Patent Landscape and Related Patents
Global and Regional Patent Environment
- DK2213661 exists within a dense patent landscape, especially within Europe and globally if related applications exist.
- It's essential to examine filing counterparts in major jurisdictions (e.g., EP, US, JP) to understand its regional breadth.
- European Patent Office (EPO) filings can provide insight into similar claims or family members extending patent protection across Europe.
Patent Families and Continuations
- The patent family might include divisional or continuation applications, broadening overall protection.
- Related patents may cover different aspects—such as synthesis, formulation, or specific therapeutic uses—creating a layered patent arsenal.
Potential Patent Challenges or Infringements
- Prior art in chemical and pharmaceutical disclosures may threaten the novelty or inventive step.
- Similar compounds patented by competitors can lead to licensing negotiations or litigation.
- Patent offices’ opposition procedures can narrow or invalidate claims if prior art is compelling.
Competitive Landscape
- Key competitors likely hold patents on similar compounds or methods.
- Patent strategies may include “patent thickets” to block market entry or secure exclusivity.
- Freedom-to-operate analyses are critical to avoid infringement liabilities.
Legal Status and Maintenance
- Patent maintenance fees and legal status must be monitored to ensure ongoing enforceability.
- Challenged or narrowed patents can influence market exclusivity periods.
Implications for Stakeholders
- Pharmaceutical Companies: Should analyze claim scope for patent enforcement and upcoming challenges.
- Researchers: Need to understand the patent landscape so as not to infringe and to identify avenues for innovation.
- Legal Professionals: Must evaluate claim validity, scope, and landscape for licensing and litigation.
Conclusion
DK2213661's claims appear strategically positioned within the pharmaceutical patent landscape, offering protection over a specific compound, its uses, or formulations. The patent's scope, nuanced by both broad and narrow claims, underpins its market exclusivity. However, the densely populated landscape of pharmaceutical patents necessitates ongoing vigilance regarding prior art, related families, and potential infringement issues.
Key Takeaways
- DK2213661’s scope hinges on its claim breadth; broader claims offer extensive protection but are susceptible to validity challenges.
- Its patent landscape features potential family members and related patents, braiding protection across regions.
- Protecting such patents involves continuous monitoring of prior art and legal statuses.
- Competitors and licensors should perform thorough freedom-to-operate analyses based on the patent’s claim scope.
- Effective patent strategy in this segment includes diversification across claims and jurisdictions, alongside vigilant enforcement.
FAQs
-
What is the primary innovation protected by Denmark patent DK2213661?
The patent likely protects a novel pharmaceutical composition, use, or formulation involving a specific chemical entity or its therapeutic application.
-
How broad are the claims in DK2213661, and what does that mean for market protection?
The claims range from broad, covering a class of compounds or uses, to narrow, specifying particular embodiments. Broader claims afford wider protection but face higher scrutiny.
-
Can DK2213661 be challenged legally, and what grounds are typically used?
Yes, it can be challenged on grounds such as lack of novelty, inventive step, or obviousness, especially if prior art discloses similar compounds or methods.
-
What does the patent landscape look like for this type of pharmaceutical patent?
The landscape includes related patents in Europe and globally, with potential patent families covering compounds, uses, and formulations, creating a dense environment.
-
How should stakeholders evaluate the patent’s strength and enforceability?
By examining claim scope, patent family breadth, legal status, prior art, and regional protections—along with continuous monitoring and strategic legal counsel.
References
[1] European Patent Office, Patent family data and claim analysis.
[2] WIPO patent databases for global patent filings related to pharmaceutical innovations.
[3] Legal case studies on pharmaceutical patent challenges and validity proceedings.
